GlassScriptPhysician profile
Matthew Terrence Nitsch
NPI 1366121162
$7,342.15
in general payments reported to CMS, 2019-2025
10 companies · $6,417 in 2025
The $6,417 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $393 · 2024: $532 · 2025: $6,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,566 · Food and Beverage: $2,004 · Travel and Lodging: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,565.63 |
| Food and Beverage | $2,003.59 |
| Travel and Lodging | $1,772.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,787.92 | 2025 | Navitor |
| Medtronic, INC. | $2,055.36 | 2023-2025 | Linq II, Pulseselect, Affera Mapping System |
| Kiniksa Pharmaceuticals International, Plc | $140.88 | 2024 | Arcalyst |
| Boston Scientific Corporation | $106.99 | 2025 | Accolade Sr, Mylux Patient Kit With Mobile Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.73 | 2024-2025 | Lifevest |
| Irhythm Technologies, INC. | $63.14 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $57.71 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Lantheus Medical Imaging, INC. | $19.63 | 2023 | Definity |
| Merck Sharp & Dohme LLC | $15.34 | 2023 | Verquvo |
| Impulse Dynamics (USA) INC. | $11.45 | 2025 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nitsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.